临床外科杂志 ›› 2022, Vol. 30 ›› Issue (5): 459-462.doi: 10.3969/j.issn.1005-6483.2022.05.016

• 论著 • 上一篇    下一篇

改良格拉斯哥预后评分联合纤维蛋白原与前白蛋白比值对胸腔镜肺叶切除术治疗肺癌的预后评估价值

  

  1. 438000 湖北省黄冈市中心医院胸心血管外科 
  • 收稿日期:2021-08-16 接受日期:2021-08-16 出版日期:2022-05-20 发布日期:2022-06-20
  • 通讯作者: 詹浩东,Email:xiaoxiao12312i@163.com

The value of mGPS score combined with FPR ratio in the prognostic evaluation of thoracoscopic lobectomy for lung cancer

  1. Department of Cardiothoracic Surgery,Huanggang Central Hospital,Hubei,Huanggang 438000, China
  • Received:2021-08-16 Accepted:2021-08-16 Online:2022-05-20 Published:2022-06-20

摘要: [摘要] 目的 分析改良格拉斯哥预后评分(mGPS)联合纤维蛋白原与前白蛋白比值(FPR)对胸腔镜肺叶切除术治疗肺癌的预后评估价值。 方法 2016年10月~2019年12月我院行胸腔镜肺叶切除术治疗的肺癌病人63例。术前检测并计算FPR比值,记录mGPS。采用受试者工作特征曲线(ROC)确定FPR最佳截断值,χ2检验分析mGPS、FPR与肺癌临床病理特征关系,多因素Cox回归分析肺癌病人预后相关因素。结果 将mGPS 0分纳入正常组(38例),1~2分纳入异常组(25例)。ROC曲线得出FPR最佳截断值为0.096,将病人分为高FPR组(FPR>0.096,19例)和低FPR组(FPR≤0.096,44例)。mGPS异常、高FPR病人TNM分期 Ⅲ期比例更高(P<0.05)。mGPS正常组、低FPR组3年无病生存率高于mGPS异常组和高FPR组(78.95% vs 48.00%,75.00% vs 47.37%)(P<0.05)。18例mGPS联合FPR均异常(mGPS异常且高FPR)病人3年无病生存率(38.89%)低于二者非均异常肺癌病人(77.78%,P<0.05)。TNM Ⅲ期、mGPS异常、高FPR、mGPS联合FPR均异常均为肺癌病人预后独立危险因素(P<0.05)。结论 术前mGPS异常、高FPR的胸腔镜肺叶切除术肺癌病人生存率显著降低,二者均异常者生存率更低,mGPS联合FPR有望作为评估肺癌病人预后的有效指标。

关键词: 格拉斯哥预后评分, 纤维蛋白原与前白蛋白比值, 肺切除术, 肺癌

Abstract: [Abstract] Objective To investigate the value of modified Glasgow prognostic score(mGPS)  combined with Fibrinogen to pre-albumin ratio(FPR) in the prognostic evaluation of thoracoscopic lobectomy for lung cancer.Methods The clinical and follow-up data of 63 patients with lung cancer who underwent thoracoscopic lobectomy in Huanggang Central Hospital from October 2016 to December 2019 were retrospectively analyzed.FPR of patients before surgery was detected and calculated,and the mGPS was recorded.The receiver operating characteristic curve(ROC) was used to determine the optimal cut-off value of FPR,and χ2 test was used to analyze the relationship between mGPS,FPR and the clinicopathological characteristics of lung cancer,and single factor and multivariate Cox proportional hazard regression models were used to analyze the influence factors related to the prognosis of patients with lung cancer underwent thoracoscopic lobectomy.Results According to the mGPS,0 points were included in the normal group(38 cases),and 1~2 points were included in the abnormal group(25 cases).The best cutoff value of FPR by ROC curve was 0.096,and the patients were divided into the high FPR group(FPR>0.096,n=19) and low FPR group(FPR≤0.096,n=44).The proportion of TNM III stage in lung cancer patients with abnormal mGPS and high FPR was higher(P<0.05).The 3 year disease-free survival rate of the normal mGPS group and the low FPR group was higher than that of the abnormal mGPS group and the high FPR group(78.95% vs 48.00%,75.00% vs 47.37%)(P<0.05).The 3 year disease-free survival rate of 18 patients with abnormal mGPS combined with FPR(abnormal mGPS and high FPR) was 38.89%,which was significantly lower than that of the two non-uniform abnormal lung cancer patients(77.78%,P<0.05).TNM stage Ⅲ,abnormal mGPS,high FPR,and abnormal mGPS combined with FPR(abnormal mGPS and high FPR) were all independent risk factors of the prognosis of lung cancer patients after thoracoscopic lobectomy(P<0.05).Conclusion he survival rate of lung cancer patients undergoing thoracoscopic lobectomy with abnormal preoperative mGPS or high FPR is significantly reduced,and the survival rate of patients with both abnormalities is lower.The combination of mGPS and FPR is expected to be an effective indicator for evaluating the prognosis of lung cancer patients.

Key words: modified Glasgow prognostic score, fibrinogen to pre-albumin ratio, thoracoscopic lobectomy, lung cancer

[1] 阮添 李昌盛 杨泽天 周雪峰 王乐. 内脏胸膜侵犯对术后ⅢA/N2期非小细胞肺癌病人生存的影响:SEER数据库分析[J]. 临床外科杂志, 2022, 30(5): 448-452.
[2] 叶彬 向秋 金文杰. 叉头框蛋白Q1和细胞周期蛋白D1在非小细胞肺癌组织中的表达与临床病理特征及预后的关系[J]. 临床外科杂志, 2022, 30(5): 453-458.
[3] 高明朗 邓宇 姚颐 耿庆. 2022年V1版《NCCN非小细胞肺癌临床实践指南》更新解读[J]. 临床外科杂志, 2022, 30(1): 20-22.
[4] 陈宇 姚龙 王云海 张仁泉. 胸腔镜下肺段切除术与肺楔形切除术治疗早期肺癌围手术期相关指标比较[J]. 临床外科杂志, 2022, 30(1): 51-53.
[5] 周存荣, 黄陈军, 蔡强. Flex三维胸腔镜肺叶切除及淋巴结清扫术治疗原发性肺癌的疗效及安全性分析[J]. 临床外科杂志, 2021, 29(8): 717-720.
[6] 郑衍洪 梁柱 马炳太 黄厚沐. 左侧肺癌切除联合区域淋巴结清扫手术病人淋巴结转移与临床病理的关系分析[J]. 临床外科杂志, 2021, 29(5): 463-465.
[7] 万志华 吴瑞锋 刘伟明 蔡艳 刘博 于宁 姚轶超. 3D胸腔镜肺叶切除术治疗原发性肺癌的疗效分析[J]. 临床外科杂志, 2021, 29(3): 269-272.
[8] 陈宇, 方汉林, 刘闻. 全胸腔镜手术对肺癌病人的肿瘤标志物神经元特异烯醇化酶、降钙素原、CD3+、CD4+和CD8+的影响[J]. 临床外科杂志, 2021, 29(2): 140-142.
[9] 邴钟兴 郑志博 张家齐. 非小细胞肺癌组织驱动蛋白超家族成员2A、真核起始因子3b的mRNA表达及其临床意义[J]. 临床外科杂志, 2021, 29(12): 1123-1126.
[10] 张平弟 吴永丰. 长链非编码RNA HHIPAS1调节MAPK信号活性抑制非小细胞肺癌增殖、迁移和侵袭[J]. 临床外科杂志, 2021, 29(12): 1127-1131.
[11] 王现国 刘俊. 肺段切除术和肺楔形切除术治疗直径≤2cm的外周性肺腺癌围手术期效果分析[J]. 临床外科杂志, 2021, 29(11): 1044-1046.
[12] 孙临奥 李昌盛 周雪峰. 甘氨酸甲基转移酶在肺癌及癌旁组织中的表达及临床意义[J]. 临床外科杂志, 2021, 29(10): 945-948.
[13] 拜都如拉·艾尼吐 凯撒尔·吾甫尔 付毅 常炜 车勇. 肺叶切除术和亚肺叶切除对老年早期非小细胞肺癌病人肺功能和术后复发的影响[J]. 临床外科杂志, 2021, 29(10): 949-952.
[14] 冯浩洁 姚颐 耿庆. 美国国家综合癌症网络临床实践指南:非小细胞肺癌(2021V1)更新解读[J]. 临床外科杂志, 2021, 29(1): 25-28.
[15] 周超 李文涛 王瑞 方文涛. 双镜联合治疗同时性多原发肺癌13例临床分析[J]. 临床外科杂志, 2021, 29(1): 38-41.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 李光焰;张安平;王祥峰;等. 直肠癌切除术后吻合口狭窄14例分析[J]. 临床外科杂志, 2016, 24(10): 772 .
[2] 肖国栋;刘国辉. 跗骨窦切口联合经皮置钉技术微创治疗跟骨骨折的临床疗效分析[J]. 临床外科杂志, 2016, 24(10): 783 .
[3] 杨钦;张再重;王烈. 空肠间置术在Siewert Ⅱ型食管胃结合部腺癌中的应用[J]. 临床外科杂志, 2016, 24(11): 816 .
[4] 应敏刚;杨春康. 腹腔镜胃癌根治术并发症的防治策略[J]. 临床外科杂志, 2016, 24(11): 819 .
[5] 石汉平. 胃癌围手术期营养治疗[J]. 临床外科杂志, 2016, 24(11): 821 .
[6] 林伟箭;洪雪辉;许淑镇;等. 吸引器在腹腔镜胃癌根治术中的应用体会[J]. 临床外科杂志, 2016, 24(11): 824 .
[7] 吴川清;刘炜圳;帅晓明;等. 超声内镜在胃癌术前诊断中的应用分析[J]. 临床外科杂志, 2016, 24(11): 828 .
[8] 方军;余阳;许涛;等. 小野寺营养预后指数在胃癌患者预后评估中的价值[J]. 临床外科杂志, 2016, 24(11): 831 .
[9] 王维君;那光玮;何科基;等. 根治性淋巴结清扫联合脾切除在残胃癌手术中的临床意义探究[J]. 临床外科杂志, 2016, 24(11): 835 .
[10] 吴超;谢迪;汪全新;等. 胃癌肝转移的临床病理特征及危险因素分析[J]. 临床外科杂志, 2016, 24(11): 839 .